DALLAS, Sept. 27, 2024 /CNW/ — The board of directors today declared a quarterly dividend of $0.2775 per share on the company’s common shares, payable November 1, 2024.

Key Takeaways:

The board of directors declared a quarterly dividend of $0.2775 per share on the company’s common shares.Dividends on common stock as well as Series A and Series C preferred stock are payable on November 1, 2024.

The board of directors of AT&T (NYSE: T) today declared a quarterly dividend of $0.2775 per share on the company’s common shares.

The board of directors also declared quarterly dividends on the company’s 5.000% Perpetual Preferred Stock, Series A and the company’s 4.750% Perpetual Preferred Stock, Series C. The Series A dividend is $312.50 per preferred share, or $0.3125 per depositary share. The Series C dividend is $296.875 per preferred share, or $0.296875 per depositary share.

Dividends on the common stock and Series A and Series C preferred stock are payable on November 1, 2024, to stockholders of record of the respective shares at the close of business on October 10, 2024.

About AT&T

We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 140+ years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE:T), please visit us at about.att.com. Investors can learn more at investors.att.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/att-declares-dividends-on-common-and-preferred-shares-302261477.html

SOURCE AT&T

Hope Week 2024 Offers Five Days of Inspiration, Education, and Support for People Living with Kidney Disease, Their Families, and Healthcare Professionals

GLENDALE, Calif., Sept. 27, 2024 /PRNewswire-PRWeb/ — Renal Support Network (RSN) will host its 31st Annual Kidney Disease Education and Lifestyle Meeting from October 9th-13th, 2024. For over three decades, RSN has hosted this highly regarded event, providing education, resources, and support for people living with kidney disease, their families, and healthcare professionals. This event, aptly named Hope Week, will continue this tradition with a focus on fostering hope and empowerment for those affected by kidney disease.

Each day of the event will center on a different stage or aspect of chronic kidney disease (CKD), covering topics such as diagnosis, dialysis, kidney transplant, and daily lifestyle challenges. Esteemed healthcare professionals, along with those from within the kidney community who have learned to thrive in spite of having kidney disease, will share their expertise, advice, and personal stories, offering valuable insight into living and thriving with CKD.

RSN remains committed to equitable access to information and resources, ensuring that no individual faces barriers to participation. By utilizing a virtual platform, the meeting allows those who may face physical, geographic, or financial constraints to engage fully in the event.

Hope Week provides not only education but also inspiration and a chance to connect with a supportive community of people who have been there. It’s a unique opportunity to hear firsthand from those who have walked the path and to learn about the latest advancements in kidney care.

RSN Founder and President Lori Hartwell reflects, “Throughout my journey—marked by more than 50 surgeries, 13 years on dialysis, and four kidney transplants—I’ve faced some of life’s toughest lessons. These were not the lessons you learn in school, but ones born from personal experience. I know many of my peers share the same fears and feelings of isolation that I’ve experienced. Fear often arises from a lack of understanding, and loneliness can be eased by connecting with a community that truly understands what you’re going through. That’s exactly what Hope Week provides: five days of inspiration and education designed to address these challenges. One of the cornerstones of RSN is the motto, ‘an illness is too demanding when you don’t have hope’, and Hope Week is here to remind everyone that connection, knowledge and confidence in navigating care is within reach.”

Key Event Highlights:

There are no fees to attend.

Free Gift for Attending: All attendees receive a complimentary gift from RSN.

The event starts later in the afternoon on the weekdays so that people who work can attend.

Daily Focused Sessions: Each day will highlight a different stage or aspect of CKD, including topics such as diagnosis, dialysis, kidney transplants, and the management of daily lifestyle issues.

Expert Speakers and Panelists: Renowned healthcare professionals and experts from the kidney community will offer advice and discuss the latest developments in kidney care.

Patient and Caregiver Stories: Attendees will have the opportunity to hear inspiring personal stories from patients and caregivers who have firsthand experience managing CKD.

Interactive Q&A Sessions: Participants will be able to engage directly with speakers and panelists, asking questions and gaining insight into various aspects of kidney disease management.

Access for All: The virtual platform ensures that individuals from across the globe can participate, regardless of their location or circumstances.

Networking and Support: Hope Week will also feature opportunities to connect with others who are experiencing similar challenges, creating a supportive and uplifting environment.

Youth and Family Day: Parents share their tips for coping with challenges of a busy family life and young adults share their stories about transitioning to adulthood, finding independence, a career, dating and school.

Lifestyle Expo: Explore virtual booths featuring kidney-friendly products, services, and resources.

To see the full agenda and to register go to RSNHope.org/HopeWeek.

RSN would like to thank our 2024 Hope Week sponsors: Akebia, Amgen, Alexion, Ardelyx, AstraZeneca and U.S. Renal Care.

The Renal Support Network is a Registered 501(c)(3) Non-profit and serve people throughout the United States.

Lori Hartwell founded Renal Support Network in 1993 to empower people who have kidney disease to become knowledgeable about their illness, proactive in their care, hopeful about their future and make friendships that last a lifetime. Lori suffered kidney failure at the age of two, survived 50+ surgeries and 13 years of dialysis, and is now living with her fourth kidney transplant.

RSN’s hopeful and life-enriching, non-medical programs help people who have kidney disease and their families, whether they are in the early stages of the disease, are on dialysis, or have received a transplant. www.RSNhope.org.

Media Contact

Suzette Maffi, Renal Support Network, 1 (818) 543-0896, Info@RSNhope.org, https://www.rsnhope.org/

View original content to download multimedia:https://www.prweb.com/releases/renal-support-network-to-host-31st-annual-kidney-disease-education-and-lifestyle-meeting-virtually-302259594.html

SOURCE Renal Support Network

Jacobs retains its innovative, next-generation data solutions and digital technologies business

Newly streamlined portfolio enables company to focus on distinct strategies in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water

DALLAS, Sept. 27, 2024 /PRNewswire/ — Jacobs (NYSE: J) announced today the completion of the spin-off of its Critical Mission Solutions and Cyber & Intelligence government services businesses (the “Separated Business”) and merger with Amentum Parent Holdings LLC, forming an independent, publicly traded company called Amentum Holdings, Inc. (NYSE: AMTM) (“Amentum”). The combination creates a robust, leading government advanced engineering and technology solutions business.

The transaction marks an important milestone in Jacobs’ journey to become a more focused and higher value company. Jacobs will continue to be a premier provider of science-based consulting and advisory solutions focused on addressing some of the world’s most complex critical infrastructure and sustainability challenges with leading positions in the attractive advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water sectors. Jacobs also retains its innovative, next-generation data solutions and digital technologies business, which is core to delivering digitally enabled critical infrastructure solutions to its clients.

“A simplified Jacobs accelerates our evolution to a more resilient, focused, higher-growth critical infrastructure player, positioning us to unlock high-margin work while solidifying our leadership in fast-growing market sectors aligned to long-term megatrends like critical infrastructure, life sciences and semiconductors,” said Jacobs Chair & CEO Bob Pragada. “With our rich history of solving some of the biggest challenges for our clients and society, we’re building on our experience and challenging ourselves to not just meet expectations but to exceed them – redefining what success looks like as a leader in these high-growth sectors.”

Jacobs’ CFO Venk Nathamuni added, “We are steadfast in our commitment to providing high-value solutions with improved margins, supported by our emphasis on operational excellence and execution to continue to drive value for our stakeholders. We look forward to sharing our strategic plan for the future of Jacobs at our upcoming Investor Day on February 18, 2025, in Miami.”

As further detailed in the information statement included as part of the registration statement on Form 10 filed by Amentum with the U.S. Securities and Exchange Commission (the “SEC”), immediately after completion of the spin-off and merger transactions, Jacobs’ shareholders held approximately 51% of the issued and outstanding shares of common stock of Amentum, and Jacobs held approximately 7.5%. An additional amount of approximately 4.5% of the issued and outstanding common stock of Amentum (the “contingent consideration”) has been placed in escrow, to be released and delivered in the future to Jacobs and its shareholders or the former sole equity holder of Amentum, depending on the achievement of certain fiscal year 2024 operating profit targets by the Separated Business. To the extent Jacobs and its shareholders become entitled to any portion of the contingent consideration, the first 0.5% of the outstanding shares of Amentum will be released from escrow and delivered to Jacobs. Any further contingent consideration to which Jacobs and its shareholders may become entitled will be distributed on a pro rata basis to Jacobs’ shareholders as of a record date to be determined in the future. Any shares of contingent consideration to which Jacobs and its shareholders do not become entitled to receive will be delivered to the former equityholder of Amentum.

Jacobs expects to file a Form 8-K with the SEC containing unaudited preliminary pro forma consolidated financial information to reflect the Separated Businesses as part of Jacobs’ discontinued operations no later than October 3, 2024. In addition, Jacobs intends to make available on a voluntary basis, substantially concurrently with the filing of the Form 8-K, certain supplemental financial information regarding independent Jacobs on its website.

At Jacobs, we’re challenging today to reinvent tomorrow – delivering outcomes and solutions for the world’s most complex challenges. With a team of approximately 45,000, we provide end-to-end services in advanced manufacturing, cities & places, energy, environmental, life sciences, transportation and water. From advisory and consulting, feasibility, planning, design, program and lifecycle management, we’re creating a more connected and sustainable world. See how at jacobs.com and connect with us on LinkedIn, Instagram, X and Facebook.

Forward-Looking Statement Disclaimer
Certain statements contained in this press release constitute forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not directly relate to any historical or current fact. When used herein, words such as “expects,” “anticipates,” “believes,” “seeks,” “estimates,” “plans,” “intends,” “future,” “will,” “would,” “could,” “can,” “may,” “target,” “goal” and similar words are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements we make concerning our expectations as to our future growth, prospects, financial outlook and business strategy, including our expectations for the benefits to be achieved through the spin-off and merger of the Separated Business, and any assumptions underlying any of the foregoing. Although such statements are based on management’s current estimates and expectations, and/or currently available competitive, financial, and economic data, forward-looking statements are inherently uncertain, and you should not place undue reliance on such statements as actual results may differ materially. We caution the reader that there are a variety of risks, uncertainties and other factors that could cause actual results to differ materially from what is contained, projected or implied by our forward-looking statements. Such factors include the uncertainties as to the impact of the recently completed separation transaction (hereinafter referred to as the “Separation Transaction”) pursuant to which we spun off and merged  the Separated Business with Amentum  (together, “new Amentum “) on Jacobs’ and new Amentum’s businesses, including a possible impact on Jacobs’ credit profile, and a possible decrease in the trading price of Jacobs’ and/or the new Amentum’s shares, uncertainties as to  the final allocation of the shares of new Amentum held in escrow based on the  Separated Business achieving specific fiscal 2024 profit targets and the value to be derived from the disposition of Jacobs’ stake in new Amentum, unexpected costs, charges or expenses related to the provision of transition services in connection with the  Separation Transaction, business and management strategies and the growth expectations of new Amentum. In addition, such factors may include other factors related to our business, such as our ability to fully execute on our corporate strategy, including our ability to invest in the tools needed to implement our strategy, competition from existing and future competitors in our target markets, our ability to achieve the cost-savings and synergies contemplated by our recent acquisitions within the expected time frames or to achieve them fully and to successfully integrate acquired businesses, the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from evolving business strategies, including on the Company’s ability to operate as a separate public-company without the benefit of the resources and capabilities divested as part of the Separated Business, or to maintain its culture and retain key personnel, customers or suppliers, the impact of any pandemic, and any resulting economic downturn on our results, prospects and opportunities, measures or restrictions imposed by governments and health officials in response to the pandemic, the timing of the award of projects and funding and potential changes to the amounts provided for under the Infrastructure Investment and Jobs Act, as well as other legislation related to governmental spending, any changes in U.S. or foreign tax laws, statutes, rules, regulations or ordinances that may adversely impact our future financial positions or results of operations, financial market risks that may affect the Company, including by affecting the Company’s access to capital, the cost of such capital and/or the Company’s funding obligations under defined benefit pension and postretirement plans, as well as general economic conditions, including inflation and the actions taken by monetary authorities in response to inflation, changes in interest rates, and foreign currency exchange rates, changes in capital markets, instability in the banking industry, or the impact of a possible recession or economic downturn on our results, prospects and opportunities, and geopolitical events and conflicts among others. The impact of such matters includes, but is not limited to, the possible reduction in demand for certain of our product solutions and services and the delay or abandonment of ongoing or anticipated projects due to the financial condition of our clients and suppliers or to governmental budget constraints or changes to governmental budgetary priorities; the inability of our clients to meet their payment obligations in a timely manner or at all; potential issues and risks related to a significant portion of our employees working remotely; illness, travel restrictions and other workforce disruptions that have and could continue to negatively affect our supply chain and our ability to timely and satisfactorily complete our clients’ projects; and the inability of governments in certain of the countries in which we operate to effectively mitigate the financial or other impacts of any future pandemics or infectious disease outbreaks on their economies and workforces and our operations therein. The foregoing factors and potential future developments are inherently uncertain, unpredictable and, in many cases, beyond our control. For a description of these and additional factors that may occur that could cause actual results to differ from our forward-looking statements see our Annual Report on Form 10-K for the year ended September 29, 2023, and in particular the discussions contained therein under Item 1 – Business; Item 1A – Risk Factors; Item 3 – Legal Proceedings; and Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations, and Part II, Item 1A – Risk Factors, in our most recently filed Quarterly Report on Form 10-Q, as well as the Company’s other filings with the U.S. Securities and Exchange Commission. The Company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law.

For press/media inquiries:
media@jacobs.com  

Logo – https://mma.prnewswire.com/media/656171/Jacobs_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jacobs-advances-strategic-transformation-with-completion-of-previously-announced-spin-off-and-merger-302261381.html